Korean J Urol.  2015 Jun;56(6):455-460. 10.4111/kju.2015.56.6.455.

Analysis of factors affecting spontaneous expulsion of ureteral stones that may predict unfavorable outcomes during watchful waiting periods: What is the influence of diabetes mellitus on the ureter?

• Choi T
• Yoo KH
• Choi SK
• Kim DS
• Lee DG
• Min GE
• Jeon SH
• Lee HL
• Jeong IK

• KMID: 2160586
• DOI: http://doi.org/10.4111/kju.2015.56.6.455

Abstract

PURPOSE
The aim of our study was to evaluate the association of several factors with spontaneous stone expulsion, including ureteral stone characteristics (size, location, hydronephrosis, perinephric stranding), types of medications prescribed (alpha-blocker, low-dose steroid), and other possible demographic and health-history factors (gender, age, serum creatinine, underlying diabetes mellitus [DM], and hypertension).
MATERIALS AND METHODS
A total of 366 patients with ureteral stones were enrolled. All patients underwent watchful waiting without any invasive procedures. Initial diagnoses of ureteral stones were confirmed by computed tomography scans, which were taken at approximately 1-month intervals to check for stone expulsion. Univariate and multivariate analyses were conducted to identify significant factors that contributed to stone expulsion.
RESULTS
Among 366 patients, 335 patients (91.5%) experienced spontaneous stone passage during a mean follow-up period of 2.95+/-2.62 weeks. The patients were divided into two groups depending on the success of spontaneous stone passage. Univariate analyses revealed that stone location (p=0.003), stone size (p=0.021), and underlying DM (p<0.001) were significant predictors of stone passage. Multivariate analyses confirmed that stone size (p=0.010), stone location (p=0.008), and underlying DM (p=0.003) were independent predictive factors affecting stone passage.
CONCLUSIONS
Stone size, location, and underlying DM were confirmed to be significant predictive factors for spontaneous passage of ureteral stones. Urologists should consider active procedures, such as shock wave lithotripsy or ureteroscopy, rather than conservative management in patients presenting with proximally located stones, large ureteral stones, or underlying DM.

Keyword

Diabetes mellitus; Therapeutics; Ureteral calculi; Urolithiasis

MeSH Terms

Adult
Aged
Diabetes Complications/*therapy
Female
Humans
Male
Middle Aged
Prognosis
Remission, Spontaneous
Retrospective Studies
Tomography, X-Ray Computed
Treatment Outcome
Ureteral Calculi/pathology/radiography/*therapy
*Watchful Waiting

Reference

1. Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J Nephrol. 2000; 13:Suppl 3. S45–S50.

2. Teichman JM. Clinical practice: acute renal colic from ureteral calculus. N Engl J Med. 2004; 350:684–693.

3. Bihl G, Meyers A. Recurrent renal stone disease-advances in pathogenesis and clinical management. Lancet. 2001; 358:651–656.

4. Tiselius HG. Metabolic evaluation and therapy. Curr Opin Urol. 2000; 10:545–549.

5. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003; 63:1817–1823.

6. Smith RD, Shah M, Patel A. Recent advances in management of ureteral calculi. F1000 Med Rep. 2009; 1:53.

7. Lipkin M, Shah O. The use of alpha-blockers for the treatment of nephrolithiasis. Rev Urol. 2006; 8:Suppl 4. S35–S42.

8. Matlaga BR. American Board of Urology. Contemporary surgical management of upper urinary tract calculi. J Urol. 2009; 181:2152–2156.

9. Preminger GM, Tiselius HG, Assimos DG, Alken P, Buck AC, Gallucci M, et al. 2007 Guideline for the management of ureteral calculi. Eur Urol. 2007; 52:1610–1631.

10. Hollingsworth JM, Rogers MA, Kaufman SR, Bradford TJ, Saint S, Wei JT, et al. Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet. 2006; 368:1171–1179.

11. Bae SR, Seong JM, Kim LY, Paick SH, Kim HG, Lho YS, et al. The epidemiology of reno-ureteral stone disease in Koreans: a nationwide population-based study. Urolithiasis. 2014; 42:109–114.

12. Richardson CD, Donatucci CF, Page SO, Wilson KH, Schwinn DA. Pharmacology of tamsulosin: saturation-binding isotherms and competition analysis using cloned alpha 1-adrenergic receptor subtypes. Prostate. 1997; 33:55–59.

13. Sigala S, Dellabella M, Milanese G, Fornari S, Faccoli S, Palazzolo F, et al. Evidence for the presence of alpha1 adrenoceptor subtypes in the human ureter. Neurourol Urodyn. 2005; 24:142–148.

14. Coll DM, Varanelli MJ, Smith RC. Relationship of spontaneous passage of ureteral calculi to stone size and location as revealed by unenhanced helical CT. AJR Am J Roentgenol. 2002; 178:101–103.

15. Boyarsky S, Labay P, Pfautz CJ. The effect of nicotine upon ureteral peristalsis. South Med J. 1968; 61:573–579.

16. Davenport K, Timoney AG, Keeley FX Jr. Effect of smooth muscle relaxant drugs on proximal human ureteric activity in vivo: a pilot study. Urol Res. 2007; 35:207–213.

17. Roshani H, Dabhoiwala NF, Dijkhuis T, Pfaffendorf M, Boon TA, Lamers WH. Pharmacological modulation of ureteral peristalsis in a chronically instrumented conscious pig model. I: Effect of cholinergic stimulation and inhibition. J Urol. 2003; 170:264–267.

18. Daneshgari F, Moore C. Diabetic uropathy. Semin Nephrol. 2006; 26:182–185.

19. Schulman CC, Duarte-Escalante O, Boyarsky S. The ureterovesical innervation: a new concept based on a histochemical study. Br J Urol. 1972; 44:698–712.

20. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008; 358:580–591.

21. Jeong IK, Oh da H, Park SJ, Kang JH, Kim S, Lee MS, et al. Inhibition of NF-κB prevents high glucose-induced proliferation and plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Exp Mol Med. 2011; 43:684–692.

22. Chiong M, Morales P, Torres G, Gutierrez T, Garcia L, Ibacache M, et al. Influence of glucose metabolism on vascular smooth muscle cell proliferation. Vasa. 2013; 42:8–16.

23. Segura JW, Preminger GM, Assimos DG, Dretler SP, Kahn RI, Lingeman JE, et al. The American Urological Association. Ureteral Stones Clinical Guidelines Panel summary report on the management of ureteral calculi. J Urol. 1997; 158:1915–1921.